-
Teleflex Signs New Agreement with HealthTrust
Post on 12/12/17
-
Aesculap Biologics Launches New Website
Post on 12/11/17
-
Recro Pharma Secures $100 Million Credit Facility
Post on 11/20/17
-
Onconova Therapeutics Prices Public Offering of Common Stock
Post on 11/10/17
-
Teva: Stop 'Tucking These Away'
Post on 11/9/17
-
Here's Why Merck & Co., Inc. Tanked 14% in October
Post on 11/9/17
-
Healthcare Administrative Partners’ Clinical Analytics Innovation Receives Industry Recognition
Post on 11/6/17
-
The Cost Benefit of Health Care Transparency
Post on 11/6/17
-
5 Tips To Help Americans Prepare For Open Enrollment And Save On Healthcare Costs
Post on 11/6/17
-
AmerisourceBergen Corporation 2017 Q4 - Results - Earnings Call Slides
Post on 11/6/17
-
Teva Punished After Weak Outlook
Post on 11/6/17
-
Teva: Value Trap
Post on 11/6/17
-
Merck: A Slow And Steady Dividend Grower, But Do Better Alternatives Exist?
Post on 11/6/17
-
Interview with Mike Daley, CEO of OrthogenRx - Part III
Post on 12/5/17
-
Interview with Mike Daley, CEO of OrthogenRx - Part II
Post on 11/30/17
-
Interview with Mike Daley, CEO of OrthogenRx - Part I
Post on 11/27/17
-
Onconova Therapeutics to Provide Corporate Update
Post on 11/5/17
-
Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Post on 11/5/17
-
Interview with Steve Wray, CEO of CloudMine - Part III
Post on 11/9/17
-
Interview with Steve Wray, CEO of CloudMine - Part II
Post on 11/7/17
-
Interview with Steve Wray, CEO of CloudMine - Part I
Post on 11/1/17
-
Idera Pharmaceuticals Prices Public Offering of Common Stock
Post on 10/26/17
-
West Announces Third-Quarter 2017 Results
Post on 10/26/17
-
Mylan Wins UK Court Ruling Related to Copaxone 40 mg/mL Patent
Post on 10/26/17
-
Pacira Pharmaceuticals and TELA Bio Announce Equity Agreement
Post on 10/25/17
